FDA Can Post On ClinicalTrials.gov, But Unlikely To Use Authority, Agency Says
This article was originally published in The Pink Sheet Daily
Executive Summary
Lack of funding and lack of an enforcement mechanism prevent the agency from taking a more active role in ensuring industry compliance with posting requirements. Sens. Johnson and Dodd appear willing to give FDA more enforcement authority.